Hyloris Pharmaceuticals SA (EBR: HYL)
Belgium
· Delayed Price · Currency is EUR 5.30
-0.24 (-4.33%)
Dec 20, 2024, 5:35 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €148.40 million as of December 20, 2024. Its market cap has decreased by -54.31% in one year.
Market Cap
148.40M
Enterprise Value
122.33M
Revenue
6.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.30
Market Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 148.40M, a decrease of -39.35%. That is a compound annual growth rate of -10.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 148.40M | -58.43% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | 245.41M | 0.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 36.50B |
| UCB SA | 35.40B |
| Financière de Tubize SA | 6.12B |
| Fagron NV | 1.32B |
| Ion Beam Applications SA | 388.11M |
| Onward Medical N.V. | 218.23M |
| Sequana Medical NV | 33.95M |